Centene FY2025 EPS Estimate Reduced by Cantor Fitzgerald

Centene Corporation (NYSE:CNC - Free Report) - Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings per share (EPS) estimates for Centene in a report released on Wednesday, July 2nd. Cantor Fitzgerald analyst S. James now anticipates that the company will earn $4.27 per share for the year, down from their previous estimate of $7.27. Cantor Fitzgerald currently has a "Overweight" rating and a $65.00 target price on the stock. The consensus estimate for Centene's current full-year earnings is $6.86 per share. Cantor Fitzgerald also issued estimates for Centene's FY2026 earnings at $7.27 EPS.

Several other brokerages also recently weighed in on CNC. Wall Street Zen downgraded Centene from a "strong-buy" rating to a "buy" rating in a report on Monday, April 28th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $48.00 price objective (down previously from $75.00) on shares of Centene in a research report on Wednesday. Barclays cut their price objective on Centene from $65.00 to $45.00 and set an "equal weight" rating for the company in a research report on Wednesday. Robert W. Baird cut their price objective on Centene from $71.00 to $69.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Finally, Jefferies Financial Group cut their price objective on Centene from $64.00 to $61.00 and set a "hold" rating for the company in a research report on Tuesday, April 29th. Ten equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, Centene has an average rating of "Hold" and an average target price of $68.87.

Centene Stock Performance

Shares of NYSE CNC traded down $0.51 during mid-day trading on Friday, hitting $33.28. 33,741,422 shares of the company were exchanged, compared to its average volume of 5,457,554. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.65. The stock has a 50 day simple moving average of $55.93 and a 200-day simple moving average of $59.04. Centene has a 1-year low of $33.30 and a 1-year high of $80.59. The firm has a market cap of $16.56 billion, a price-to-earnings ratio of 4.96, a price-to-earnings-growth ratio of 0.45 and a beta of 0.44.

Centene (NYSE:CNC - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $2.90 earnings per share for the quarter, beating the consensus estimate of $2.52 by $0.38. The business had revenue of $46.62 billion during the quarter, compared to the consensus estimate of $43.16 billion. Centene had a return on equity of 14.56% and a net margin of 2.04%. The company's revenue was up 15.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.26 earnings per share.

Hedge Funds Weigh In On Centene

Several institutional investors and hedge funds have recently modified their holdings of CNC. Norges Bank purchased a new position in shares of Centene in the 4th quarter valued at $1,536,167,000. AQR Capital Management LLC raised its stake in shares of Centene by 42.7% in the 1st quarter. AQR Capital Management LLC now owns 11,049,494 shares of the company's stock valued at $669,820,000 after acquiring an additional 3,306,796 shares during the period. Nuveen LLC acquired a new position in Centene during the 1st quarter worth $146,557,000. Boston Partners grew its holdings in Centene by 155.3% during the 1st quarter. Boston Partners now owns 3,901,603 shares of the company's stock worth $236,802,000 after acquiring an additional 2,373,280 shares in the last quarter. Finally, Two Sigma Investments LP grew its holdings in Centene by 1,788.1% during the 4th quarter. Two Sigma Investments LP now owns 2,245,511 shares of the company's stock worth $136,033,000 after acquiring an additional 2,126,582 shares in the last quarter. Hedge funds and other institutional investors own 93.63% of the company's stock.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.